Talis Biomedical Corp Quarterly Costs and Expenses in USD from Q1 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Talis Biomedical Corp quarterly/annual Costs and Expenses history and growth rate from Q1 2022 to Q2 2024.
  • Talis Biomedical Corp Costs and Expenses for the quarter ending June 30, 2024 was $9.58M, a 43.6% decline year-over-year.
  • Talis Biomedical Corp Costs and Expenses for the twelve months ending June 30, 2024 was $55.5M, a 40.4% decline year-over-year.
  • Talis Biomedical Corp annual Costs and Expenses for 2023 was $68.9M, a 42.5% decline from 2022.
  • Talis Biomedical Corp annual Costs and Expenses for 2022 was $120M, a 40% decline from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $55.5M $9.58M -$7.39M -43.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 $62.9M $14.2M -$6.03M -29.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $68.9M $14.7M -$13.7M -48.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $82.7M $17.1M -$10.5M -38% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $93.1M $17M -$10.9M -39% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 $104M $20.2M -$15.9M -44.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $120M $28.4M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $27.6M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $27.8M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $36.2M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.